GSK position history
The shares of GSK that CAUSEWAY CAPITAL MANAGEMENT LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2022 Q2: 258,163 shares, $11M, 0.28% of portfolio, New
- 2022 Q3: 183,544 shares, $5.4M, 0.15% of portfolio, Reduce −28.9%
- 2022 Q4: 237,033 shares, $8.3M, 0.24% of portfolio, Add +29.1%
- 2023 Q1: 319,160 shares, $11M, 0.27% of portfolio, Add +34.6%
- 2023 Q2: 399,430 shares, $14M, 0.37% of portfolio, Add +25.2%
- 2023 Q3: 564,747 shares, $20M, 0.54% of portfolio, Add +41.4%
- 2023 Q4: 795,441 shares, $29M, 0.75% of portfolio, Add +40.8%
- 2024 Q1: 737,185 shares, $32M, 0.83% of portfolio, Reduce −7.3%
- 2024 Q2: 753,535 shares, $29M, 0.79% of portfolio, Add +2.2%
- 2024 Q3: 897,406 shares, $37M, 0.90% of portfolio, Add +19.1%
- 2024 Q4: 1,076,580 shares, $36M, 0.83% of portfolio, Add +20.0%
- 2025 Q1: 1,107,923 shares, $43M, 0.90% of portfolio, Add +2.9%
- 2025 Q2: 1,107,076 shares, $43M, 0.67% of portfolio, Reduce −0.1%
- 2025 Q3: 1,177,001 shares, $51M, 0.67% of portfolio, Add +6.3%
- 2025 Q4: 33,897 shares, $1.7M, 0.02% of portfolio, Reduce −97.1%
- 2026 Q1: 11,110 shares, $613K, <0.01% of portfolio, Reduce −67.2%
- 2026 Q2: 7,163 shares, $375K, <0.01% of portfolio, Reduce −35.5%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|